Open label extension study finds Viloxazine demonstrated good safety and tolerability profile, and long term treatment led to continued improvement in ADHD symptoms, quality of life, and executive function
Read Full Article
#Viloxazine #ADHDResearch #MentalHealth #ClinicalStudy #QualityOfLife
Read Full Article
#Viloxazine #ADHDResearch #MentalHealth #ClinicalStudy #QualityOfLife
SpringerLink
An Open-Label Extension Study Assessing the Long-Term Safety and Efficacy of Viloxazine Extended-Release Capsules in Adults with…
CNS Drugs - Viloxazine ER (extended-release capsules; Qelbree®) is a nonstimulant medication that has been approved by the United States Food and Drug Administration (FDA) for treatment of...
❤2😨1
A small early-phase human clinical study suggests that a single 10 mg dose of psilocybin transiently reduces compulsive, but not obsessive, symptoms in adults with OCD, with effects peaking at one week and no full psychedelic experience. 🌱💊🧠✨
Read Full Article
#PsilocybinResearch #OCDTreatment #MentalHealthAwareness #ClinicalStudy #PsychedelicScience
Read Full Article
#PsilocybinResearch #OCDTreatment #MentalHealthAwareness #ClinicalStudy #PsychedelicScience
❤3🤮2🥰1